• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Study of the anti-arrhythmic effects of omega-3 PUFA to long QT syndrome

Research Project

Project/Area Number 25461633
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Pediatrics
Research InstitutionTokyo Women's Medical University

Principal Investigator

Furutani Michiko  東京女子医科大学, 医学部, 研究生 (40398805)

Co-Investigator(Kenkyū-buntansha) HAYAMA EMIKO  東京女子医科大学, 医学部, 非常勤講師 (00349698)
NAKANISHI TOSHIO  東京女子医科大学, 医学部, 研究生 (90120013)
Project Period (FY) 2013-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
KeywordsQT延長症候群 / 多価不飽和脂肪酸 / EPA/AA / EPA/AA比 / PUFA
Outline of Final Research Achievements

In the myocardial Na + channel (Nav1.5), INa suppression was observed in both of the cell with the ω-3 PUFA (EPA) or ω-6 -PUFA (AA). In the long QT syndrome (LQTS) patients, the mean value of the concentration ratio of EPA and AA (EPA / AA ratio), showed a low value compared with the value of the general Japanese. In the group of 20 years of age or older with a syncope episode, EPA / AA ratio had an significant low value compared to the value of the group with no syncope episode. PUFA was found to modulate the Nav1.5 channel. The low-EPA / AA ratio raises the risk of syncope episode was considered.

Report

(4 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2014 Research-status Report
  • 2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi